Researchers are developing a crisper-on-chip technology for point-of-care diagnostics, which may enable rapid detection of various pathogens, including respiratory viruses and antibiotic-resistant bacteria. The technology involves the use of microfluidic chips and biosensors, and has potential applications in disease detection and pandemic surveillance. Advances in this field are being explored through various studies and research initiatives, with potential to expand the diagnostic capabilities of crisper technology.